Perspectives of Rare Disease Social Media Group Participants on Engaging With Genetic Counselors: Mixed Methods Study.
Autorzy:
Yabumoto M; Department of Genetics, Stanford University School of Medicine, Stanford, CA, United States. Miller E; Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, United States. Rao A; Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, United States. TaborHK; Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, United States.; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States. Ormond KE; Department of Genetics, Stanford University School of Medicine, Stanford, CA, United States.; Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, United States.; Health Ethics and Policy Lab, Department of Health Sciences and Technology, Swiss Federal Institute of Technology (Eidgenössische Technische Hochschule Zurich), Zurich, Switzerland. Halley MC; Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, United States.
Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience.
Autorzy:
Porter KM; Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, Washington. Kauffman TL; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Koenig BA; Institute for Health and Aging, University of California, San Francisco, California. Lewis KL; Medical Genomics and Metabolic Genetics Branch of the National Human Genome Research Institute, Bethesda, Maryland. Rehm HL; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Partners Personalized Medicine, Boston, Massachusetts.; Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Massachusetts. Richards CS; Knight Diagnostic Laboratories and Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon. Strande NT; Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. TaborHK; Stanford Center for Biomedical Ethics, Palo Alto, California. Wolf SM; University of Minnesota Law School, Medical School and Consortium on Law and Values in Health, Environment & the Life Sciences, Minneapolis, Minnesota. Yang Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas. Amendola LM; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington. Azzariti DR; Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Massachusetts. Berg JS; Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Bergstrom K; Texas Children's Cancer Center and the Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas. Biesecker LG; Medical Genomics and Metabolic Genetics Branch of the National Human Genome Research Institute, Bethesda, Maryland. Biswas S; Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Bowling KM; Hudson Alpha Institute for Biotechnology, Huntsville, Alabama. Chung WK; Department of Pediatrics, Columbia University, New York, New York.; Department of Medicine, Columbia University Medical Center, New York, New York. Clayton EW; Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee. Conlin LK; Division of Genomic Diagnostics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Cooper GM; Hudson Alpha Institute for Biotechnology, Huntsville, Alabama. Dulik MC; Division of Genomic Diagnostics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Garraway LA; Eli Lilly and Company, Indianapolis, Indiana. Ghazani AA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology and Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Green RC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Partners Personalized Medicine, Boston, Massachusetts.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Hiatt SM; Hudson Alpha Institute for Biotechnology, Huntsville, Alabama. Jamal SM; Department of Molecular Genetics, University of Toronto, Toronto, Ontario. Jarvik GP; Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington.; Department of Genome Sciences, University of Washington, Seattle, Washington. Goddard KAB; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Wilfond BS; Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.
Correction: Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Autorzy:
Emond MJ; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America. Louie T; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America. Emerson J; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America; Center for Clinical and Translational Medicine, Seattle Children's Research Institute Seattle, Washington, United States of America. Chong JX; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America. Mathias RA; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. Knowles MR; Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Rieder MJ; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. TaborHK; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America; Trueman-Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, Washington, United States of America. Nickerson DA; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America. Barnes KC; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America. Go L; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America. Gibson RL; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America; Division of Pulmonary Medicine, Seattle Children's Hospital, Seattle, Washington, United States of America. Bamshad MJ; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America; Division of Genetic Medicine, Seattle Children's Hospital, Seattle, Washington, United States of America.
Challenges in the use of direct-to-consumer personal genome testing in children.
Autorzy:
TaborHK; University of Washington School of Medicine and Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital, Seattle, WA 98101, USA. holly.tabor@seattlechildrens.org Kelley M
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies